Salesforce.com (CRM) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Salesforce (CRM) is retreating 2.5% after the tech giant provided lower-than-expected 2025 revenue guidance and sparked worries about the outlook of its AI agent. CRM specializes in marketing software ...

Although earnings exceeded consensus estimates of $2.61 per share, revenue missed the projected $10.04 billion target.

Even during a down period for the markets, Salesforce has gone against the grain, climbing to $274.18. Its shares have ...

SAN FRANCISCO & SINGAPORE, March 12, 2025--Salesforce (NYSE: CRM), the world’s #1 AI CRM ... in accordance with New York Stock Exchange Rule 303A.08. SAN FRANCISCO & SUNNYVALE, Calif., ...

JP Morgan Sees Long-Term Upside Meanwhile, J.P. Morgan also reiterated its Buy rating on CRM stock with a price target of $380. Five-star-rated analyst Mark Murphy stated that Salesforce’s is ...

The latest ratings from Citigroup, Citizens Capital and BMO Capital imply a 26.57% upside for Salesforce. CRM Stock Price Action: Salesforce stock was trading at $308.12 at the time of publication.

The Recent Price Action of CRM Stock In the last month, the shares have dropped 12%, while they have retreated 8% in the last three months. While we acknowledge the potential of CRM, our ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...